The U.S. Food and Drug Administration (FDA) has approved a drug to control seizures in dogs with idiopathic epilepsy, a type ...

FDA approves KBroVet chewable tablets for managing canine idiopathic epilepsy.

The DETECT study is the first randomised controlled trial comparing Minder System implants to standard care monitoring.

Epilepsy patients who want to learn how to manage their own unique symptoms can now get individualized information via tablet computer through a research project at the University of Illinois at ...

Surgery led to a reduction in premature mortality among adults with drug-resistant focal epilepsy beyond 15 years and gradually normalised their long-term survival to more closely resemble that of the ...